Robert J. Gould - 26 Jun 2025 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Robert J. Gould
Issuer symbol
FULC
Transactions as of
26 Jun 2025
Net transactions value
$0
Form type
4
Filing time
30 Jun 2025, 16:15:05 UTC
Previous filing
18 Jun 2024
Next filing
21 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gould Robert J Director C/O FULCRUM THERAPEUTICS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE /s/ Greg Tourangeau, as attorney-in-fact for Robert J. Gould 30 Jun 2025 0001577034

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +36,000 $0.000000 36,000 26 Jun 2025 Common Stock 36,000 $7.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 26, 2025 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.